Aliath Bioventures, the healthcare impact investment platform of AltamarCAM Partners, appoints Philippe Monteyne, MD, PhD as a new Partner to reinforce the company’s healthcare investment team.

As of 16th November 2023, Philippe Monteyne will join the team responsible for Alta Life Sciences Spain I FCR and the newly launched, ACP Aliath Bioventures II FCR (ABV II), specialised in investing in companies in the healthcare sector.

For the past eight years, Philippe has been a Senior Partner of the private equity fund Fund+ in Belgium, having contributed to multiple investments including very profitable ones such as Ogeda and Iteos.

The firm also reinforces the life sciences team with the appointment of Joana Correia as a senior analyst that join Beatriz Gandarias, Jose Maria Fernández and the Alta Life Sciences team

Fuente: AltamarCAM Partners / Aliath Bioventures

https://www.aliathbio.com/appointment-philippe-monteyne/
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Xcalibur Smart Mapping strengthens its g...

by MCH Private Equity

​Xcalibur Smart Mapping, recognised as the global leader in airborne...

Photos Stream